tiprankstipranks
Advertisement
Advertisement
Ligand sees FY26 EPS $8-$9, consensus $8.42
PremiumThe FlyLigand sees FY26 EPS $8-$9, consensus $8.42
1M ago
Ligand reports Q4 core EPS $2.02, consensus $1.50
Premium
The Fly
Ligand reports Q4 core EPS $2.02, consensus $1.50
1M ago
Ligand price target raised to $239 from $231 at H.C. Wainwright
Premium
The Fly
Ligand price target raised to $239 from $231 at H.C. Wainwright
1M ago
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
PremiumRatingsPromising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
4M ago
Ligand Pharma’s Strong Financial Outlook and Strategic Investments Justify Buy Rating
Premium
Ratings
Ligand Pharma’s Strong Financial Outlook and Strategic Investments Justify Buy Rating
4M ago
Ligand price target raised to $230 from $220 at Stifel
Premium
The Fly
Ligand price target raised to $230 from $220 at Stifel
4M ago
Ligand to host 2025 Investor Day
PremiumThe FlyLigand to host 2025 Investor Day
4M ago
Ligand reiterates 2025 core adjusted EPS view $7.40-$7.65, consensus $7.62
Premium
The Fly
Ligand reiterates 2025 core adjusted EPS view $7.40-$7.65, consensus $7.62
4M ago
Ligand Pharma’s Strategic Positioning and Growth Prospects Justify Buy Rating
Premium
Ratings
Ligand Pharma’s Strategic Positioning and Growth Prospects Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100